tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PHRRF Stock Latest News

PharmaTher Advances Towards FDA Approval for Ketamine with Resubmission Plan
Company AnnouncementsPharmaTher Advances Towards FDA Approval for Ketamine with Resubmission Plan
11d ago
PharmaTher expects to submit minor amendment to CRL by end of February
PremiumThe Fly
PharmaTher expects to submit minor amendment to CRL by end of February
11d ago
PharmaTher Eyes FDA Approval and Future Growth in Ketamine Market
PremiumCompany Announcements
PharmaTher Eyes FDA Approval and Future Growth in Ketamine Market
2M ago
PharmaTher ‘on track’ to submit responses to FDA in February
PremiumThe Fly
PharmaTher ‘on track’ to submit responses to FDA in February
2M ago
PharmaTher Updates on Ketamine Drug Application
PremiumCompany Announcements
PharmaTher Updates on Ketamine Drug Application
3M ago
PharmaTher initiates activities to address ‘minor deficiencies’ in ketamine NDA
PremiumThe FlyPharmaTher initiates activities to address ‘minor deficiencies’ in ketamine NDA
3M ago
PharmaTher Updates on FDA Ketamine Application
Premium
Company Announcements
PharmaTher Updates on FDA Ketamine Application
3M ago
PharmaTher says FDA grants post-complete letter clarification meeting
Premium
The Fly
PharmaTher says FDA grants post-complete letter clarification meeting
3M ago
PharmaTher Secures FDA Meeting for Ketamine Drug
PremiumCompany Announcements
PharmaTher Secures FDA Meeting for Ketamine Drug
3M ago
PharmaTher granted post-CRL clarification meeting request by FDA
PremiumThe Fly
PharmaTher granted post-CRL clarification meeting request by FDA
3M ago
PharmaTher Faces FDA Setback for Ketamine Drug
PremiumCompany Announcements
PharmaTher Faces FDA Setback for Ketamine Drug
4M ago
PharmaTher receives CRL from FDA for ketamine ANDA
PremiumThe Fly
PharmaTher receives CRL from FDA for ketamine ANDA
4M ago
PharmaTher Closes in on FDA Ketamine Approval Date
PremiumCompany AnnouncementsPharmaTher Closes in on FDA Ketamine Approval Date
6M ago
PharmaTher receives GDUFA goal date of October 29 for ketamine NDA
Premium
The Fly
PharmaTher receives GDUFA goal date of October 29 for ketamine NDA
6M ago
PharmaTher’s Potential Breakthrough in Monkeypox Treatment
Premium
Company Announcements
PharmaTher’s Potential Breakthrough in Monkeypox Treatment
6M ago
PharmaTher’s Sairiyo Advances with Clinical Trial Approval
PremiumCompany Announcements
PharmaTher’s Sairiyo Advances with Clinical Trial Approval
6M ago
PharmaTher’s Sairiyo receives approval to initiate Phase 1 trial of PD-001
PremiumThe Fly
PharmaTher’s Sairiyo receives approval to initiate Phase 1 trial of PD-001
6M ago
PharmaTher Advances Clinical Trials for New Treatment
PremiumCompany Announcements
PharmaTher Advances Clinical Trials for New Treatment
9M ago
PharmaTher’s Sairiyo submits CTA for Phase 1 study of cepharanthine
PremiumThe Fly
PharmaTher’s Sairiyo submits CTA for Phase 1 study of cepharanthine
9M ago
PharmaTher Nears FDA Decision on Ketamine Application
PremiumCompany AnnouncementsPharmaTher Nears FDA Decision on Ketamine Application
10M ago
PharmaTher announces assigned GDUFA goal data for Ketamine ANDA
Premium
The Fly
PharmaTher announces assigned GDUFA goal data for Ketamine ANDA
10M ago
PharmaTher Advances Cepharanthine Phase 1 Trials
Premium
Company Announcements
PharmaTher Advances Cepharanthine Phase 1 Trials
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >